NEIL GARRY ARTHUR
SEC CIK 1586785 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics, Inc. | CSO | 190.3K | $29.6K | — | 8 | 2021-12-10 | 2026-05-21 |
Most active insiders at AVTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sullivan Christopher Ryan | CFO | — | $3.72M |
| 2 | Doyle Mittie | Chief Medical Off | — | $2.98M |
| 3 | VARKI PAUL | CLO | — | $1.51M |
| 4 | Goldman Jonathan | Dir | — | $163.0K |
| 5 | Chan Mitchell | Dir | — | $72.5K |
| 6 | Riley Jennifer | Chief Strategy Off | — | $52.0K |
| 7 | Truex Samantha | Dir | — | — |
| 8 | KANTOFF AARON | Dir | — | — |
| 9 | NEIL GARRY ARTHUR | CEO, Dir | — | — |
| 10 | KAPLAN GILLA | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-26 16:10 | 2026-05-21 | AVTX | Avalo Therapeutics, Inc. | NEIL GARRY ARTHUR | CEO, Dir | A - Grant | $0.00 | +100.2K | 190.3K | +111% | $0 | |
| D | 2026-03-31 | 2026-03-28 | AVTX | Avalo Therapeutics, Inc. | NEIL GARRY ARTHUR | CEO, Dir | M - OptEx | — | +64.9K | 112.0K | +138% | — |
| D | 2026-03-31 | 2026-03-28 | AVTX | Avalo Therapeutics, Inc. | NEIL GARRY ARTHUR | CEO, Dir | F - Tax | $13.89 | -21.9K | 90.1K | -20% | -$304.1K |
| D | 2025-04-01 | 2025-03-28 | AVTX | Avalo Therapeutics, Inc. | NEIL GARRY ARTHUR | CEO | F - Tax | $8.46 | -17.8K | 47.1K | -27% | -$150.5K |
| D | 2025-04-01 | 2025-03-28 | AVTX | Avalo Therapeutics, Inc. | NEIL GARRY ARTHUR | CEO | M - OptEx | — | +64.9K | 64.9K | +108,112% | — |
| 2023-06-13 | 2023-06-09 | AVTX | Avalo Therapeutics, Inc. | NEIL GARRY ARTHUR | CEO, COB, Dir | P - Purchase | $3.42 | +4,000 | 13.2K | +43% | +$13.7K | |
| 2022-12-12 | 2022-12-09 | AVTX | Avalo Therapeutics, Inc. | NEIL GARRY ARTHUR | CEO, COB, Dir | P - Purchase | $4.42 | +2,083 | 9,220 | +29% | +$9,207 | |
| 2021-12-14 | 2021-12-10 | AVTX | Avalo Therapeutics, Inc. | NEIL GARRY ARTHUR | CSO | P - Purchase | $1.57 | +4,267 | 85.6K | +5% | +$6,699 |
Purchase Sale Sale after option exercise All abbreviations